National Institutes of Health (NIH)

Combination immunotherapy shrank a variety of metastatic gastrointestinal cancers

NIH trial shows new form of TIL therapy effective against colon, rectum, pancreas, and bile duct tumors.

President Trump nominated Dr. Bhattacharya for the position on Nov. 26, 2024, and he was confirmed by the U.S. Senate on March 25, 2025.

NIH-supported study reveals new risk group for future high blood pressure, heart disease.